Catalyst Wire Dossier Catalyst Wire Dossier

ARK-E021 Foam

· M. Arkin 1999 Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARK-E021 Foam, covering 2013-12-03 to 2013-12-03. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients [Phase 1, Phase 2]

See pricing